跳到主要內容區塊
胃腸肝膽科 Division Of Gastroenterology and Hepatology
:::快捷選單
icon網路掛號 icon看診進度 icon即時動態 衛教專區 icon服務諮詢 icon交通指南 icon健康檢查 icon常見問答 該看哪一科
:::胃腸肝膽科 > 公開資訊 > 論文發表

論文發表

引用 (7)
更新日期 2022/8/15 17:08:40
點閱 3733

108-110年台中榮民總醫院 醫學研究論文目錄
 
108年SCI論文
編號 論文題目 期刊名稱 作者
1 Ectopic papilla of Vater in duodenum bulb: A hospital-based study MEDICINE 第一作者:彭彥鈞
通訊作者:Wai-Keung Chow
2 Association of Daily Aspirin Therapy with Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B. JAMA Internal Medicine 第一作者:李騰裕
通訊作者:吳俊穎
3 Association of virological breakthrough and clinical outcomes in entecavir-treated HBeAg-positive chronic hepatitis B PLoS One 第一作者:黃儀倢
通訊作者:彭彥鈞
共同作者:楊勝舜
4 Sorafenib treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic factors of the viral and tumor status MEDICINE 第一作者:李少武
通訊作者:李少武
共同作者:楊勝舜
5 Reactivation of hepatitis B virus infection following rituximab treatment in HBsAg-negative, HBcAb-positive rheumatoid arthritis patients: A long-term, real-world observation. Int J Rheum Dis 第一作者:陳一銘
共同作者:楊勝舜
6 Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis. J Gastroenterol Hepatol 第一作者:劉振驊
共同作者:楊勝舜
7 Lusutrombopag for the Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Invasive Procedures (L-PLUS 2). Hepatology 第一作者:Peck-Radosavljevic M
共同作者:楊勝舜
8 Comparisons of hepatitis C viral replication in patients with rheumatoid arthritis receiving tocilizumab, abatacept and tofacitinib therapy. Ann Rheum Dis 第一作者:陳一銘
共同作者:楊勝舜
 
109年SCI論文
編號 論文題目 期刊名稱 作者
1 Glecaprevir/pibrentasvir for Patients With Chronic Hepatitis C Virus Infection and Severe Renal Impairment Journal of Viral Hepatitis  第一作者:劉振驊             通訊作者:高嘉宏
2 Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction? JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 第一作者:徐士哲
通訊作者:高嘉宏
3 Distinct Physiological Characteristics of Isolated Laryngopharyngeal Reflux Symptoms Clinical Gastroenterology and Hepatology 第一作者:連漢仲
通訊作者:連漢仲
4 The therapeutic benefits of combined sorafenib and transarterial chemoembolization for advanced hepatocellular carcinoma Journal of Digestive Diseases 第一作者:李少武
通訊作者:李少武
5 Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection Clinical Gastroenterology and Hepatology 第一作者:李騰裕
通訊作者:吳俊穎
6 Duodenal major papilla morphology can affect biliary cannulation and complications during ERCP, an observational study BMC GASTROENTEROLOGY 第一作者:陳柏翰
通訊作者:陳家昌

110年SCI論文
編號 論文題目 期刊名稱 作者
1 Impact of overlapping functional gastrointestinal disorders on the quality of life in patients with gastroesophageal reflux disease Journal of Neurogastroenterology and Motility 第一作者:李少武      
通訊作者:張繼森                                          
2 Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial LANCET INFECTIOUS DISEASES 第一作者:許耀峻                                 
通訊作者:林肇堂
共同作者:李騰裕             
3 Reply. Dr Chuang and his colleagues raised concerns about the design and definitions of our study Clinical Gastroenterology and Hepatology 第一作者:李騰裕
通訊作者:吳俊穎
4 Long-Term Safety in HBsAg-Negative, HBcAb-Positive Patients with Rheumatic Diseases Receiving Maintained Steroid Therapy after Pulse Therapy. Journal of Clinical Medicine 第一作者:林穎正
通訊作者:楊勝舜
通訊作者:陳一銘
5 The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization MEDICINE 第一作者:李少武
通訊作者:李少武
6 Evaluating the renal safety of tenofovir disoproxil fumarate in hepatitis B patients without chronic kidney disease JOURNAL OF VIRAL HEPATITIS 第一作者:蔡炘儒
通訊作者:李騰裕
7 Hepatitis C virus-induced exosomal microRNAs and TLR7 polymorphism regulate B-cell activating factor mBio 第一作者:廖采苓
通訊作者:楊勝舜
8 Cessation of Nucleos(t)ide Analogue Therapy in Non-Cirrhotic Hepatitis B Patients with Prior Severe Acute Exacerbation Journal of Clinical Medicine 第一作者:賴佳業
通訊作者:李騰
9 Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment. Alimentary Pharmacology & Therapeutics 第一作者:劉振驊
通訊作者:高嘉宏
共同作者:楊勝舜
10 Anchoring of fully covered self-expandable metal stents: selected patients or all? ENDOSCOPY 第一作者:廖苡君
通訊作者:彭彥鈞
11 Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan. LIVER INTERNATIONAL 第一作者:陳啟益
第一作者:黃釧峰
通訊作者:余明隆
通訊作者:林漢傑
共同作者:楊勝舜
12 Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan. Hepatology International 第一作者:劉振驊
通訊作者:高嘉宏
共同作者:楊勝舜
共同作者:張崇信
共同作者:黃儀倢
13 Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan. Infectious Diseases and Therapy 第一作者:鄭斌男
通訊作者:余明隆
共同作者:楊勝舜
14 Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan. Scientific Reports 第一作者:黃釧峰
通訊作者:余明隆
共同作者:楊勝舜
15 Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis. Clinical and Molecular Hepatology 第一作者:劉振驊
通訊作者:高嘉宏
共同作者:楊勝舜
16 Drug Resistance Profile and Clinical Features for Hepatitis C Patients Experiencing DAA Failure in Taiwan. Viruses 第一作者:洪濬銘
通訊作者:陳培哲
共同作者:楊勝舜
17 Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis C. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION 第一作者:徐士哲
通訊作者:莊萬龍
共同作者:楊勝舜
18 Advances in the era of direct-acting antivirals for hepatitis C in patients with unresectable hepatocellular carcinoma. Dig Dis. 第一作者:陳立書
通訊作者:李騰裕
 

 


 

回頂端